ROHIT BHATIA | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

ROHIT BHATIA | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

ISF College of Pharmacy Moga, India

Author Profile

Early Academic Pursuits

Dr. Rohit Bhatia embarked on his academic journey with a B. Pharmacy degree from HP University, graduating with an impressive 75.5% in 2011. Building on this foundation, he pursued a Master's in Pharmacy in Pharmaceutical Chemistry from PTU University, securing a notable 74.5% in 2013. His academic pursuit culminated in a Ph.D. in Pharmaceutical Sciences from MRSPTU, Bathinda, in 2022, showcasing his dedication to advancing in the field.

Professional Endeavors

HIs professional career is marked by significant milestones. He served as an Assistant Professor of Pharmaceutical Chemistry at Laureate Institute of Pharmacy from 2013 to 2016 before transitioning to his current role as an Associate Professor at ISF College of Pharmacy from 2016 to the present. His roles have involved guiding numerous M. Pharm and Ph.D. students, totaling 27 and 3, respectively, showcasing his commitment to mentorship and education in the pharmaceutical field.

Contributions and Research Focus

With a keen interest in drug design and molecular modeling, His contributed significantly to pharmaceutical sciences. His research projects, including the synthesis and evaluation of coumarin fused/tethered nitrogen-containing heterocycles as anticancer agents and work on imidazo [2,1-b] [1,3,4] thiadiazole derivatives, highlight his expertise in synthetic medicinal chemistry and target-based drug design. Furthermore, his focus on analytical method development and bioanalysis, along with microfluidics-based analysis, underscores his multidisciplinary approach to research.

Accolades and Recognition

His contributions have been widely recognized through various grants, awards, and achievements. Notable among these are the MSME grant for developing an electrochemical device for detecting glucose levels in human saliva, received in 2022. His innovative teaching methods earned him the Best Innovative Teacher Award in Pharmaceutical Analysis at the National Pharma Summit-2023. Additionally, he has consistently won prizes and awards for his research presentations, such as the Pharma Rising Star Award and recognition for his work in repurposing drugs against SARS-CoV-2.

Impact and Influence

His work has made a tangible impact on the pharmaceutical landscape, evident from his patents and copyrights. His patents range from techniques for quantifying ascorbic acid to novel drug delivery systems and neuroprotective compounds, showcasing his diverse contributions to the field. Furthermore, his involvement in national and international conferences, along with his role as a Bentham Ambassador, speaks volumes about his influence and standing within the scientific community.

Legacy and Future Contributions

His continues to excel in academia and research, his legacy as a mentor, innovator, and contributor to pharmaceutical sciences is firmly established. His future contributions are anticipated to further push the boundaries of drug design, analytical techniques, and therapeutic innovations. Through his continued dedication to education, research, and impactful collaborations, His  is poised to leave a lasting imprint on the field of pharmaceutical sciences.

Notable Publications 

Synthetic and medicinal perspective of thiazolidinones: A review

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

Inductively coupled plasma optical emission spectrometry (ICP-OES): a powerful analytical technique for elemental analysis

Applications of various analytical techniques in quality control of pharmaceutical excipients

Design, synthesis and neuropharmacological evaluation of new 2, 4-disubstituted-1, 5-benzodiazepines as CNS active agents

Protein tyrosine phosphatase (PTP1B): a promising drug target against life-threatening ailments

based microfluidic devices: Fabrication, detection, and significant applications in various fields

Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships

Enasidenib: first mutant IDH2 inhibitor for the treatment of refractory and relapsed acute myeloid leukemia

Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors

Pradip Nirbhavane | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Pradip Nirbhavane | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Amity University, India

Author Profile

Early Academic Pursuits

Dr. Pradip Nirbhavane embarked on an illustrious academic journey starting with a Bachelor of Pharmacy from the University of Pune, where he demonstrated exceptional competence with an average of 60.95%. His pursuit of excellence continued at NIPER, SAS Nagar, where he earned an M.S. (Pharm) degree with a notable 7.1 CGPA. This solid academic foundation paved the way for his significant contributions in the field of pharmaceuticals.

Professional Endeavors

His professional journey began as a Senior Research Fellow at Lifecare Innovations Pvt Ltd, where he contributed for nearly three years. Subsequently, he joined Intas Pharmaceuticals Ltd as an Assistant Manager, accumulating valuable industry experience for over two years. Currently, he serves as an Assistant Professor at Amity University, Gurgaon, where he imparts knowledge and fosters academic growth.

Contributions and Research Focus

His research focus encompasses nanotechnology and drug delivery, with a particular emphasis on topical, oral, and parenteral drug administration. His groundbreaking work includes novel discoveries and advancements in treating conditions like Onychomycosis and uveitis, as evidenced by his publications in esteemed journals such as Advanced Drug Delivery Reviews, International Ophthalmology, and Colloids and Surfaces B: Biointerfaces.

Accolades and Recognition

Throughout his career, Dr. Nirbhavane has been honored with prestigious awards, including the "Korean Ginseng Society-International Young Scientist" award and the "University of Birmingham India Institute Fellowship." These accolades underscore his exceptional contributions and recognition within the global scientific community.

Impact and Influence

His research has made a significant impact on the pharmaceutical landscape, particularly in enhancing drug bioavailability, targeted delivery, and therapeutic efficacy. His work on lipid nanocarriers and nanostructured formulations has opened new avenues for more effective and personalized treatments across various medical conditions.

Legacy and Future Contributions

With a legacy of impactful research and academic excellence, His continues to inspire future generations of pharmaceutical scientists. His dedication to quality research, innovative methodologies, and collaborative initiatives ensures a promising future characterized by advancements in drug delivery systems and improved patient outcomes.

Notable Publications 

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder (s)

Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1

Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics

A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne

Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate

Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity

Nanolipoidal α-terpineol modulates quorum sensing regulated virulence and biofilm formation in Pseudomonas aeruginosa

Lipid nanocarrier-mediated drug delivery system to enhance the oral bioavailability of rifabutin

Nano-constructed carriers loaded with antioxidant: Boon for cardiovascular system